Form 4 Tracker
Charles W. Newton

Director · 2 filings · Latest: Apr 25, 2026

Keros Therapeutics, Inc.
NOVAVAX INC
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
NVAX
Charles W. NewtonDirectorApr 25, 2026
Option Exercise
$0.009,5209,520